Black Diamond Therapeutic Stock (NASDAQ: BDTX) stock price, news, charts, stock research, profile.
Open | $4.50 |
Close | - |
Volume / Avg. | 601.54K / 1.10M |
Day Range | $4.27 - $4.55 |
52 Wk Range | 1.62 - 7.66 |
Market Cap | $242.69M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 18.1% |
Days to Cover | 9.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Black Diamond Therapeutic (NASDAQ:BDTX) through any online brokerage.
Other companies in Black Diamond Therapeutic’s space includes: Zura Bio (NASDAQ:ZURA), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), PepGen (NASDAQ:PEPG) and Adaptimmune Therapeutics (NASDAQ:ADAP).
Black Diamond Therapeutic has a consensus price target of $14.40.
The stock price for Black Diamond Therapeutic (NASDAQ: BDTX) is $4.295 last updated September 24, 2024 at 10:11 AM EDT.
There are no upcoming dividends for Black Diamond Therapeutic.
Black Diamond Therapeutic’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for Black Diamond Therapeutic.
Black Diamond Therapeutic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.